Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $23,988,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 154 grants at over 100 hospitals in 29 countries.
University Hospital of Navarra - $100,000 USD, €92,637 EUR
$100,000.00
October 2024
Targeting Diffuse Midline Glioma vulnerabilities as a therapeutic strategy.
The Institute of Cancer Research – $111,445 USD / £85,976 GBP
$111,445.00
October 2024
Unravelling transcriptional plasticity as a non-genetic mechanism of drug resistance in DMG.
McGill University - $100,000
$100,000.00
October 2024
Understanding tumor heterogeneity and characterizing treatment responses in ACVR1-mutated diffuse midline gliomas.
Cincinnati Children’s Hospital Medical Center - $200,000
$200,000.00
October 2024
Combining FLASH and immunotherapy to target medulloblastoma relapse
Emory University / Cincinnati Children's Hospital – $93,250
$93,250.00
March 2024
SUMOylation as a novel therapeutic target in DIPG
University of Chicago Medical Center / Washington University St. Louis – $100,000
$100,000.00
December 2023
Characterizing and Targeting ABL1 and ABL2 in Medulloblastoma Leptomeningeal Dissemination.
Icahn School of Medicine at Mount Sinai – $100,000
$100,000.00
December 2023
Targeting macrophages to improve the survival of DIPG
Children’s Cancer Institute – $50,000
$50,000.00
December 2023
A novel formulation to allow the simultaneous targeting of MYCN expression and copper chelation to treat DIPG tumour and overcome multidrug resistance.
Children’s Hospital Colorado – $100,000
$100,000.00
December 2023
Dual targeting processive transcription for Myc-driven circuitry in medulloblastoma.
University of Newcastle – $116,997 USD, 173,016 AUD
$116,997.00
December 2023
(2023) Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies.
Princess Máxima Center for Pediatric Oncology – $98,306
$98,306.00
December 2023
Assessing the potential of the HDAC inhibitor givinostat ± radiotherapy for the treatment of diffuse midline glioma.
Nemours Children’s Hospital - $50,000
$50,000.00
December 2023
Treatment of Diffuse Intrinsic Pontine Glioma with the Oncolytic Zika Virus.
Icahn School of Medicine at Mount Sinai - $100,000
$100,000.00
December 2023
Preclinical evaluation of TP-0184 in an autochthonous mouse model of DIPG/DMG
The University of Alabama at Birmingham – $100,000
$100,000.00
December 2023
Intranasal Delivery of Targeting Nanotherapeutics for DIPG
Funding of PBTCF 2023 - $25,000
$25,000.00
December 2023